tyrphostin a23 has been researched along with Liver Neoplasms in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, R | 1 |
| Nishikawa, Y | 1 |
| Carr, BI | 1 |
1 other study available for tyrphostin a23 and Liver Neoplasms
| Article | Year |
|---|---|
Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation.
Topics: Carcinoma, Hepatocellular; Catechols; Cell Division; Cell Line; Enzyme Inhibitors; Epidermal Growth | 1998 |